Cargando…
Molecular classification of IDH-mutant glioblastomas based on gene expression profiles
Isocitrate dehydrogenase (IDH) mutant glioblastoma (GBM), accounts for ~10% GBMs, arises from lower grade diffuse glioma and preferentially appears in younger patients. Here, we aim to establish a robust gene expression-based molecular classification of IDH-mutant GBM. A total of 33 samples from the...
Autores principales: | Wu, Fan, Chai, Rui-Chao, Wang, Zhiliang, Liu, Yu-Qing, Zhao, Zheng, Li, Guan-Zhang, Jiang, Hao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642368/ https://www.ncbi.nlm.nih.gov/pubmed/30877769 http://dx.doi.org/10.1093/carcin/bgz032 |
Ejemplares similares
-
Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies
por: Menyhárt, Otília, et al.
Publicado: (2021) -
Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis
por: Chen, Ting-Yu, et al.
Publicado: (2020) -
Differences in gene-expression profiles in breast cancer between African and European-ancestry women
por: Ping, Jie, et al.
Publicado: (2020) -
Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma
por: Zhu, Kai, et al.
Publicado: (2020) -
Nut and peanut butter intake and the risk of colorectal cancer and its anatomical and molecular subtypes: the Netherlands Cohort Study
por: Nieuwenhuis, Lisette, et al.
Publicado: (2020)